We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+1.73%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$22.9B
AUM Growth
+$801M
Cap. Flow
+$1.26B
Cap. Flow %
5.48%
Top 10 Hldgs %
26.16%
Holding
1,655
New
269
Increased
651
Reduced
446
Closed
272

Top Buys

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$159M
2
TRP icon
TC Energy
TRP
+$105M
3
MRVL icon
Marvell Technology
MRVL
+$92.4M
4
INFY icon
Infosys
INFY
+$83.4M
5
PAAS icon
Pan American Silver
PAAS
+$81.1M

Top Sells

Rank Stock Value
1
CLS icon
Celestica
CLS
+$111M
2
SAP icon
SAP
SAP
+$107M
3
BAM icon
Brookfield Asset Management
BAM
+$98.6M
4
BNS icon
Scotiabank
BNS
+$89M
5
CNQ icon
Canadian Natural Resources
CNQ
+$81.7M

Sector Composition

Rank Sector Weight
1 Financials 23.76%
2 Technology 17.69%
3 Industrials 12.67%
4 Energy 11.54%
5 Materials 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HMC icon
526
Honda
HMC
$40.5B
$4.52M 0.02%
166,548
-501,544
-75% -$14.3M
ROP icon
527
Roper Technologies
ROP
$39.3B
$4.51M 0.02%
7,643
-4,362
-36% -$2.45M
UFCS icon
528
United Fire Group
UFCS
$1.38B
$4.47M 0.02%
151,760
+18,326
+14% +$495K
TFPM icon
529
Triple Flag Precious Metals
TFPM
$6.45B
$4.47M 0.02%
233,500
+136,900
+142% +$2.34M
FORM icon
530
FormFactor
FORM
$10.3B
$4.46M 0.02%
157,688
+60,388
+62% +$2.22M
AMRX icon
531
Amneal Pharmaceuticals
AMRX
$6.02B
$4.42M 0.02%
527,685
-27,970
-5% -$233K
DVAX
532
DELISTED
Dynavax Technologies
DVAX
$4.37M 0.02%
+336,951
New +$4.46M
AHCO icon
533
AdaptHealth
AHCO
$760M
$4.36M 0.02%
+401,985
New +$4.04M
TREE icon
534
LendingTree
TREE
$461M
$4.34M 0.02%
86,399
+36,364
+73% +$1.62M
ALHC icon
535
Alignment Healthcare
ALHC
$2.79B
$4.29M 0.02%
+230,542
New +$3.44M
VNDA icon
536
Vanda Pharmaceuticals
VNDA
$304M
$4.27M 0.02%
929,644
+110,262
+13% +$514K
PCRX icon
537
Pacira BioSciences
PCRX
$924M
$4.26M 0.02%
171,377
+127,240
+288% +$3.05M
LPL icon
538
LG Display
LPL
$3.37B
$4.25M 0.02%
1,367,184
-4,103
-0.3% -$13.4K
AMLX icon
539
Amylyx Pharmaceuticals
AMLX
$2.5B
$4.25M 0.02%
1,199,691
-63,662
-5% -$227K
ERIE icon
540
Erie Indemnity
ERIE
$13.4B
$4.23M 0.02%
10,091
-7,924
-44% -$3.23M
FLGT icon
541
Fulgent Genetics
FLGT
$513M
$4.22M 0.02%
249,659
+123,702
+98% +$2.11M
VTR icon
542
Ventas
VTR
$46.3B
$4.21M 0.02%
61,243
-80,291
-57% -$5.13M
CXW icon
543
CoreCivic
CXW
$3.13B
$4.2M 0.02%
206,965
+75,470
+57% +$1.52M
SLQT icon
544
SelectQuote
SLQT
$126M
$4.18M 0.02%
1,251,828
+478,997
+62% +$2.03M
PRIM icon
545
Primoris Services
PRIM
$4.35B
$4.17M 0.02%
72,652
+30,277
+71% +$2.19M
LGF.A
546
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$4.16M 0.02%
469,843
+131,175
+39% +$1.18M
ALKT icon
547
Alkami Technology
ALKT
$2.22B
$4.14M 0.02%
157,806
+62,557
+66% +$1.97M
TER icon
548
Teradyne
TER
$64.2B
$4.13M 0.02%
50,004
+13,188
+36% +$1.48M
LIVN icon
549
LivaNova
LIVN
$4.53B
$4.13M 0.02%
105,059
+94,457
+891% +$4.24M
ING icon
550
ING
ING
$102B
$4.11M 0.02%
209,771
+37,704
+22% +$670K
20 21
22
23 24

Similar funds

State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2025 Portfolio in Review

As of Q1 2025, Connor, Clark & Lunn Investment Management (CC&L) held 1,655 positions worth $22.9B, up 3.6% from $22.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) deployed $1.26B of net new capital in Q1 2025, opening 269 new positions and adding to 651 existing holdings. Its largest new stake was Advanced Micro Devices: 709,028 shares worth $72.8M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Celestica, an estimated $111M trimmed.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2025 buy was Advanced Micro Devices: 709,028 shares worth $72.8M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Franco-Nevada in Q1 2025, an estimated $159M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2025 reduction was Celestica, cutting an estimated $111M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Edwards Lifesciences in Q1 2025, selling an estimated $28.1M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 26% of its $22.9B portfolio in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 269 new positions and closed 272 in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 3.6% quarter-over-quarter to $22.9B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.